Agronomics

What Agronomics does

Agronomics Limited is a London-listed (AIM, ticker ANIC) closed-end investment company that provides public market access to cellular agriculture and alternative protein companies. The company was admitted to AIM in 2011 and repositioned by co-founder Jim Mellon in 2019 around clean food technologies. Agronomics invests across three technology pillars: precision fermentation (using microorganisms to produce specific proteins such as egg proteins and milk proteins), cell culture (growing animal cells into cultivated meat without animal husbandry), and enabling biomanufacturing infrastructure (commercial-scale fermentation capacity). Its portfolio spans more than 20 venture-stage companies covering beef, pork, chicken, egg proteins, dairy, palm oil alternatives, cocoa, cotton, leather, and fermentation contract manufacturing, with notable holdings including Meatly, SuperMeat, BlueNalu, Onego Bio, All G Foods, Mosa Meat, Liberation Labs, Solar Foods, Clean Food Group, Bond Pet Foods, and The EVERY Company. Several portfolio companies have achieved regulatory clearances including FDA GRAS determinations and FDA Letters of No Objection.

Agronomics' business model centers on realizing capital gains through trade sales and IPOs of its portfolio companies. The company operates as a passive investor holding both quoted and unquoted equity positions and is ungeared. Shellbay Investments Limited provides consultancy services including due diligence on prospective assets and is entitled to a 15% annual performance fee on any increase in NAV per share, subject to a high-water mark. Agronomics serves both individual retail investors and institutional investors seeking ESG-aligned exposure to food technology, distributed via the London Stock Exchange AIM listing and nominee platforms including Hargreaves Lansdown, Interactive Investor, and Interactive Brokers. The Board comprises Executive Chairman Jim Mellon, Finance Director Denham Eke, and Non-Executive Directors including Richard Reed (co-founder of Innocent Drinks), David Giampaolo (founder of Pi Capital), and Marisa Drew (Chief Sustainability Officer at Standard Chartered). Net assets stood at £139.97 million at 31 December 2025 with NAV per share of 13.78p.

The company is incorporated in the Isle of Man with its registered office in Douglas, and operates from London as its primary listing venue. Headcount is in the 1–10 range, reflecting the holding-company structure with operational execution outsourced to portfolio companies and Shellbay for due diligence. Agronomics positions itself against a global food production market valued at $10 trillion, with cultivated meat projected to reach USD 1.2–2.6 billion by 2030 and precision fermentation projected to reach USD 34.2 billion by 2031, per company materials.

Name

Agronomics

Legal name

Agronomics Limited

Website

https://agronomics.im

Company type

Public

Founded year

2011

Operating status

Operating

Headcount range

1–10 employees

Short description

Agronomics is a London-listed (AIM) closed-end investment company providing public market access to a portfolio of 20+ cellular agriculture and alternative protein companies, serving individual and institutional investors seeking ESG-aligned exposure to clean food technologies.

Ownership category

akta.pro rank

Product category

Thematic Equity Investment (Cellular Agriculture / Alternative Proteins)

akta.pro primary industry

Agriculture & Food / AgTech Growth Equity (FSANACAM)

akta.pro secondary industries

Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO) (AFANAKAF), Manufacturing, Private Label & Co-Manufacturing for Animal Diets (HLAMAHAO)

Keywords

• Venture capital investments
• Alternative protein investments
• Cellular agriculture investment
• Clean food technologies
• Publicly traded investment fund

Headquarters

HQ city

Douglas

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Personnel, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Investment Returns and Capital Gains: Agronomics generates returns through equity investments in early-stage cellular agriculture and alternative protein companies. The company aims to deliver capital growth by realizing capital gains when valuations become excessive or following trade sales. As a closed-end investment firm, it operates as a passive investor holding both quoted and unquoted equity positions.
2. Consultancy and Performance Fees: Shellbay Investments Limited, which provides consultancy services to Agronomics, is entitled to reimbursement of costs and an annual performance fee equal to 15% of any increase in the company's net asset value per share, subject to a high-water mark.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Agronomics is a London AIM-listed closed-end investment company that provides public market access to a diversified portfolio of venture-stage companies developing cellular agriculture and clean food technologies. Through its ANIC-listed shares, investors gain exposure to three core technology pillars — precision fermentation, cell culture (cultivated meat and seafood), and enabling biomanufacturing infrastructure — spanning more than 20 portfolio companies across beef, pork, chicken, egg proteins, dairy, palm oil alternatives, cocoa, cotton, leather, and contract fermentation manufacturing.

Product overview

Agronomics is a London-listed investment company focused on clean food technologies, operating as a venture-stage investment vehicle rather than a product manufacturer. The company provides public market access to cellular agriculture and alternative protein investments through three core technology pillars: Precision Fermentation, Cell Culture, and Enabling Biomanufacturing Technologies. Its portfolio comprises over 20 venture-stage companies spanning cultivated meat (beef, pork, chicken, seafood), precision fermentation-derived proteins (egg, dairy, designer proteins), and enabling infrastructure (commercial-scale fermentation facilities). Key portfolio companies include Meatly (cultivated pet food), SuperMeat (cultivated chicken), BlueNalu (cultivated seafood), Onego Bio (precision fermentation egg proteins), All G Foods (precision fermentation dairy), Clean Food Group (sustainable palm oil alternatives), Liberation Labs (commercial fermentation services), The EVERY Company (egg proteins via fermentation), Mosa Meat (cultivated beef), and Solar Foods (novel sustainable protein Solein). The portfolio covers protein categories including beef, pork, chicken, egg proteins, dairy, palm oil, cocoa, cotton, leather, and fermentation contract manufacturing.

Differentiator

Problem solved

Functional benefit

Products and services

• Agronomics AIM-Listed Investment Vehicle (ANIC) The company's core standalone product is its publicly traded ordinary shares on the London AIM market (ticker ANIC; OTCMKTS AGNMF), which provide individual and institutional investors with diversified, liquid exposure to a portfolio of more than 20 venture-stage cellular agriculture and clean food companies.
• Shellbay Consultancy & Performance-Fee Services External portfolio management and due diligence services delivered to Agronomics by Shellbay Investments Limited under a performance-fee arrangement aligned with NAV growth.

Quantifiable outcome

• NAV increased 11.7% to 13.78 pence per share for H1 FY2026
• +2 more outcomes

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core.

• Armor ProtéinescoreStrategic or Co-development Partner · 11 December 2025All G formed a strategic joint venture with French milk ingredient supplier Armor Protéines to produce and commercialize bovine lactoferrin and human milk proteins. The JV combines All G's fermentation technology with Armor Protéines' manufacturing infrastructure.
• Hill's Pet NutritioncoreStrategic or Co-development PartnerHill's Pet Nutrition collaborated with Bond Pet Foods on the development of the Lamb Protein Yeast ingredient, which received FDA Letter of No Objection. The companies are moving into commercialization of the fermented lamb protein in the U.S. pet food market.
• AjinomotocoreStrategic or Co-development PartnerSuperMeat has entered into R&D and technology development agreements with Ajinomoto as part of its licensing-led commercialization strategy, extending the existing R&D framework agreement.
• Micarna Group (Migros)coreStrategic or Co-development PartnerSuperMeat has extended its collaboration with Micarna, a subsidiary of Swiss retail group Migros Group, for production and distribution. SuperMeat has filed for regulatory approval in Switzerland with Micarna as the production and distribution partner.
• Shellbay Investments LimitedcoreImplementation/ SI/ Consulting PartnerShellbay Investments Limited provides consultancy services to Agronomics, including procuring and coordinating due diligence in relation to prospective asset purchases. Shellbay is entitled to reimbursement of costs and an annual performance fee equal to 15% of any increase in NAV.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Beyond Meat: Nasdaq-listed plant-based meat pioneer offering public-market investors direct exposure to the alternative protein theme. Comparable to Agronomics as a US-listed gateway to alt-protein, though operational rather than investment-vehicle structure.
• Oatly Group: Nasdaq-listed oat-dairy alternative offering public-market exposure to plant-based foods. Comparable to Agronomics as a publicly traded vehicle giving investors thematic alt-protein access, though at the operating-company level.

Emerging players

• Eat Just: Private cultivated meat and plant-based company (GOOD Meat division). Agronomics holds similar cultivated-meat exposure via portfolio companies like SuperMeat and Mosa Meat, and Eat Just represents one of the more advanced commercialised cultivated-meat players in the sector.
• Perfect Day: Private precision fermentation company producing animal-free whey protein. Highly comparable to Agronomics' precision fermentation portfolio theme (Onego Bio, All G, Formo, EVERY), though at the operating-company level rather than as a listed investment vehicle.
• Else Nutrition Holdings: TSX-listed plant-based nutrition company targeting infant and toddler markets. Comparable as a small-cap listed alt-protein play offering public investors thematic exposure, overlapping with Agronomics' plant-based portfolio (LiveKindly, Rebellyous).
• AquaBounty Technologies: Nasdaq-listed company producing genetically engineered salmon — a regulated bio-engineered food product. Comparable as a small-cap listed exposure to cellular/molecular agriculture innovation, similar to the regulatory complexity of Agronomics' cultivated seafood holding BlueNalu.
• Local Bounti: NYSE-listed indoor vertical-farming AgTech company. Comparable as a publicly listed AgTech/food-innovation equity offering retail investors thematic exposure to food-system transformation, overlapping with Agronomics' alternative agriculture thesis.

Broad incumbents

• Vital Farms: Nasdaq-listed pasture-raised egg company in the premium sustainable-food category. Tangentially comparable as a public sustainable-food equity with consumer-brand exposure that overlaps with Agronomics' egg-protein fermentation investments (Onego Bio, EVERY).

Others

• AppHarvest: Nasdaq-listed AgTech company using controlled-environment agriculture. Comparable as a small-cap publicly traded AgTech equity, though illustrating the operational and capital-execution risks facing AgTech listed vehicles that differ from Agronomics' pure-investment model.
• Burra Foods: Australian dairy ingredients manufacturer that has invested in All G's precision fermentation dairy platform. Comparable as an adjacent industry participant enabling cellular agriculture commercialisation, illustrating the corporate-partnership model Agronomics' portfolio companies are pursuing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/agronomics
• LinkedInlinkedin.com/company/agronomics-limited
• Xx.com/agronomicsltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments44 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Agronomics